about
Anticholinergic medication use and dementia: latest evidence and clinical implicationsCumulative use of strong anticholinergics and incident dementia: a prospective cohort studyProbing peripheral and central cholinergic system responsesSymptom management in the older adult: 2015 updateHuman models as tools in the development of psychotropic drugsScopolamine-induced "cholinergic stress test" in the elderly.Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.Modes and models of forebrain cholinergic neuromodulation of cognition.Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort studyα1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.Mild cognitive impairment: an epidemiological perspective.The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease riskPharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older AdultsEnabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study.Safe prescribing of physical health medication in patients with dementia.Pharmacological models in Alzheimer's disease researchPharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation.The use of medicines with anticholinergic effects in older people: a population study in an urban area of Sweden.Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjectsCharacterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study.Effects of scopolamine on interhemispheric EEG coherence in healthy subjects: analysis during rest and photic stimulation.Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.
P2860
Q28068339-34E1F3BD-4E40-47E8-9F70-05078C1D6BFEQ28255929-EF8A27CB-160D-4813-9AB8-A15CFBD078FAQ28344836-EC83213D-D18A-4FBA-B50F-5968BA918F84Q30374202-E848AE3C-0D34-410F-8C1A-1E9711F02134Q30473426-C7546AC0-D9C4-4A31-A658-6EFD01ADA2A3Q34038700-531352EF-4643-4868-946F-DFC5A71A24B8Q34104256-6FF46437-C44D-43FD-8797-3A43338DE764Q34355481-908FAEA1-AD00-4EC6-A505-5A43440EE442Q34407945-8A7D4001-C48E-40F6-AB3A-EC5F877DD96DQ35183611-25517504-38F9-44C0-AF7B-6E74D2C7EAB5Q35236834-45183E88-37A4-43EA-8F79-F8AA9C38C699Q36007813-1C7AA54D-6E01-4B45-96E6-6EF312324D15Q36860047-B2F85841-6127-40FC-AB2B-A867F5A2B268Q37268405-1DFC802E-706B-470F-91F3-008BB74BBFF3Q38178373-86D5ABFD-BE14-4AD8-9C2B-AC81721AEFC8Q38237044-3BA697E7-53AB-4254-97AB-5B2549C7AC0CQ38578433-B8B28C26-C839-44D7-9FF5-6E4555E872FEQ38786004-45AC7E16-E1E9-4883-9F06-9D472F7EC785Q39371998-9CFB61FD-260D-48C0-A9FA-D18B148435BBQ41634921-9B2131F0-07B1-49B4-ABF9-0D8DF5DA5892Q42428489-2F93E5DF-B53C-4B46-9D2D-43342552FD48Q44736078-E42FA31A-C1E9-42F8-AB9D-34092EC05C84Q52026642-3EF4C412-3314-4E6A-A1C5-AE22F3BACFA9Q53422654-2B23FE4F-0D70-4FC3-ACF7-5F2F8E4E151B
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Hypersensitivity to scopolamine in the elderly.
@ast
Hypersensitivity to scopolamine in the elderly.
@en
Hypersensitivity to scopolamine in the elderly.
@nl
type
label
Hypersensitivity to scopolamine in the elderly.
@ast
Hypersensitivity to scopolamine in the elderly.
@en
Hypersensitivity to scopolamine in the elderly.
@nl
prefLabel
Hypersensitivity to scopolamine in the elderly.
@ast
Hypersensitivity to scopolamine in the elderly.
@en
Hypersensitivity to scopolamine in the elderly.
@nl
P2093
P2860
P356
P1433
P1476
Hypersensitivity to scopolamine in the elderly.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF02245172
P577
1992-01-01T00:00:00Z
P6179
1003915111